29 March 2019 - Italfarmaco Group is pleased to announce the marketing of GhemaXan, the first biosimilar of Enoxaparin Sodium developed and produced in Italy
Read more
25 February 2019 - Italfarmaco launches NUPERAL in Italy, the first drug as fixed combination of doxilamine succinate and pyridoxine hydrochloride authorized for the symptomatic treatment of nausea and vomiting during pregnancy
Read more
20 February 2019 - Gordon Research Conference on Cancer Genetics and Epigenetics
Read more
31 January 2019 - Italfarmaco strengthen its presence in rare disease area by launching the medicinal product VOTUBIA
Read more
09 November 2018 - TRiNDS and Italfarmaco Announce US Patient Advocacy Partnership for EPIDYS Trial of Givinostat for Duchenne Muscular Dystrophy
Read more
26 September 2018 - New Marketing launch of SONIDOR, a food supplement based on hawthorn, lavender and hops extracts that induce sleep and relaxation
Read more
07 September 2018 - World Duchenne Awareness Day
Italfarmaco committed to its mission to contribute to the improvement of the quality and the prolongation of human lifespan, is proud to support the Duchenne Community and to recognize the World Duchenne Awareness Day.
Read more
25 July 2018 - World Drug Safety Congress Europe, 10-11 Settembre 2018, Amsterdam
Invited speaker: Margherita D’Antuono, QPPV Italfarmaco SpA
Read more
22 September 2017 - NATALBEN, line of pregnancy supplements of Italfarmaco, is the partner of Walking Day, the first Italian event dedicated to Walking
THE ART OF WALKING IN PREGNANCY IN THE WALKING DAY OF FLORENCE (October 1st) and MILAN (28/29 October)
Read more
21 September 2017 - ITF BECKER. A new therapeutic approach to the Becker Muscular Dystrophy (BMD)
Paolo Bettica, Vice President R&D ITALFARMACO S.p.A, interviewed for the ITF Becker project
Read more